SARS-CoV-2 infections in professional orchestra and choir musicians-a prospective cohort study.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 18 03 2022
accepted: 13 09 2022
pubmed: 30 9 2022
medline: 5 11 2022
entrez: 29 9 2022
Statut: ppublish

Résumé

During the COVID-19 pandemic, rehearsal and concert activities of professional orchestras and choirs were severely restricted based on the assumption of particularly high infection risks associated with wind instruments and singing. Therefore, our primary objective was to determine the incidence of SARS-CoV-2 infections in orchestra and choir musicians compared to controls. We also assessed influenza, flu, upper respiratory tract infections, and course of illness. Musicians from professional orchestras and choirs and controls from 23 institutions throughout Germany were included in a prospective cohort study. Data were collected from October 2020 to June 2021 by weekly online surveys. A mixed-effects cox proportional hazards model was used to assess the effect of exposure by professional activity on SARS-CoV-2 infection. In 1,097 participants (46.7 years (SD 10.3); 46.8% female; 705 orchestra, 154 choir, and 238 control subjects) 40 SARS-CoV-2 infections occurred. Cases per person-years were 0.06 in orchestras, 0.11 in choirs, and 0.03 in controls. Hazard ratios compared to controls were 1.74 (95% CI 0.58 to 5.25, p = 0.320) for orchestra musicians and 2.97 (0.87 to 10.28, p = 0.087) for choir singers. Infection source was suspected predominantly in private contexts. Disease courses were mild to moderate. Other respiratory infections were reported in 6.1% of study weeks in orchestras, 10.1% in choirs, and 8.0% in controls. Sick leave days of total study days were 0.5, 2.1 and 1.3%, respectively. This epidemiologic study during the pandemic in professional musicians indicates no increased risk of SARS-CoV-2 infections in orchestra musicians and a trend towards increased risk in choir singers compared to controls. However, the exact routes of infection could not be validated. If appropriate hygiene concepts are adhered to, safe orchestra and choir activity appears possible in pandemic times.

Identifiants

pubmed: 36173478
doi: 10.1007/s10654-022-00917-x
pii: 10.1007/s10654-022-00917-x
pmc: PMC9519404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1061-1070

Informations de copyright

© 2022. The Author(s).

Références

Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med. 2021;174(1):69–79. https://doi.org/10.7326/M20-5008 .
doi: 10.7326/M20-5008 pubmed: 32941052
Jarvis MC. Aerosol transmission of SARS-CoV-2: physical principles and implications. Front Public Health. 2020;8:590041. https://doi.org/10.3389/fpubh.2020.590041 .
doi: 10.3389/fpubh.2020.590041 pubmed: 33330334 pmcid: 7719704
Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020;8(7):658–9. https://doi.org/10.1016/S2213-2600(20)30245-9 .
doi: 10.1016/S2213-2600(20)30245-9 pubmed: 32473123 pmcid: 7255254
Hess M. [Choir singing and singing lessons in times of Corona]. Hamburg: Deutsche Stimmklinik 2020 21.4.2020.
Mürbe D, Bischoff P, Fleischer M, Gastmeier P. [Assessment of the risk of infection with SARS-CoV-2 viruses during singing]. Berlin: Klinik für Audiologie und Phoniatrie, Institut für Hygiene und Umweltmedizin, Charité - Universitätsmedizin Berlin 2020.
Mürbe D, Fleischer M, Lange J, Rotheudt H, Kriegel M. Aerosol emission is increased in professional singing. depositonce.tu-berlin.de. 2020:1–10.
Westphalen C, Kniesburges S, Veltrup R, et al. Sources of aerosol dispersion during singing and potential safety procedures for singers. J Voice: Off J Voice Found. 2021. https://doi.org/10.1016/j.jvoice.2021.03.013 .
doi: 10.1016/j.jvoice.2021.03.013
Hamner L, Dubbel P, Capron I, et al. High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):606–10. https://doi.org/10.15585/mmwr.mm6919e6 .
doi: 10.15585/mmwr.mm6919e6 pubmed: 32407303
Becher L, Gena AW, Alsaad H, Richter B, Spahn C, Voelker C. The spread of breathing air from wind instruments and singers using schlieren techniques. Indoor Air. 2021;31(6):1798–814. https://doi.org/10.1111/ina.12869 .
doi: 10.1111/ina.12869 pubmed: 34121229
Spahn C, Hipp AM, Schubert B, et al. Airflow and air velocity measurements while playing wind instruments, with respect to risk assessment of a SARS-CoV-2 infection. Int J Environ Res Public Health. 2021;18(10):5413. https://doi.org/10.3390/ijerph18105413 .
doi: 10.3390/ijerph18105413 pubmed: 34069419 pmcid: 8159134
Brandt L. Measurement of aerosol from brass and woodwind instruments playing 5 minutes in distances from 0.5 to 4 meter. Odense: Center for Performing Arts Medicine, Department of Occupational and Environmental Health, Center for Performing Arts Medicine DoOaEH; 2020.
Kähler CJ, Hain R. [Making music during the pandemic - what does science advise? About the risk of infection when singing in choirs and making music with wind instruments]. Neubiberg: Institut für Strömungsmechanik und Aerodynamik, Universität der Bundeswehr München 2020 8.5.2020.
Gantner S, Echternach M, Veltrup R, et al. Impulse dispersion of aerosols during playing wind instruments. PLoS ONE. 2022;17(3):e0262994. https://doi.org/10.1371/journal.pone.0262994 .
doi: 10.1371/journal.pone.0262994 pubmed: 35239657 pmcid: 8893631
He R, Gao L, Trifonov M, Hong J. Aerosol generation from different wind instruments. J Aerosol Sci. 2021;151:105669. https://doi.org/10.1016/j.jaerosci.2020.105669 .
doi: 10.1016/j.jaerosci.2020.105669 pubmed: 32952210
Bahl P, de Silva C, Bhattacharjee S, et al. Droplets and aerosols generated by singing and the risk of coronavirus disease 2019 for choirs. Clin Infect Dis. 2021;72(10):e639–41. https://doi.org/10.1093/cid/ciaa1241 .
doi: 10.1093/cid/ciaa1241 pubmed: 32945338
Graf S, Engelmann L, Jeleff Wölfler O, et al. Reopening the bavarian state opera safely: hygiene strategies and incidence of COVID-19 in artistic staff during theater season 2020/2021. J Voice Off J Voice Found. 2021. https://doi.org/10.1016/j.jvoice.2021.11.012 .
doi: 10.1016/j.jvoice.2021.11.012
Dinnes J, Sharma P, Berhane S, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2022;7:CD013705. https://doi.org/10.1002/14651858.CD013705.pub3 .
doi: 10.1002/14651858.CD013705.pub3 pubmed: 35866452
Filchakova O, Dossym D, Ilyas A, Kuanysheva T, Abdizhamil A, Bukasov R. Review of COVID-19 testing and diagnostic methods. Talanta. 2022;244:123409. https://doi.org/10.1016/j.talanta.2022.123409 .
doi: 10.1016/j.talanta.2022.123409 pubmed: 35390680 pmcid: 8970625
Lu L, Zhong W, Bian Z, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: a systematic review and meta-analysis. J Infect. 2020;81(4):e18–25. https://doi.org/10.1016/j.jinf.2020.07.002 .
doi: 10.1016/j.jinf.2020.07.002 pubmed: 32634459 pmcid: 7334925
Treskova-Schwarzbach M, Haas L, Reda S, et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021;19(1):212. https://doi.org/10.1186/s12916-021-02058-6 .
doi: 10.1186/s12916-021-02058-6 pubmed: 34446016 pmcid: 8390115
Robert Koch-Institut. Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19. Stand: 14.07.2021. 2021. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html . Accessed 22.07.2021. Accessed August 08, 2022.
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines: National Institutes of Health2021.
Brüggenjürgen B, Stricker HP, Krist L, et al. Impact of public health interventions to curb SARS-CoV-2 spread assessed by an evidence-educated Delphi panel and tailored SEIR model. J Public Health. 2021. https://doi.org/10.1007/s10389-021-01566-2 .
doi: 10.1007/s10389-021-01566-2 pubmed: 34026423
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2020. http://www.r-project.org/index.html
Robert Koch Institut. Situation reports from Monday to Friday. Robert Koch Institut, Berlin. 2022. https://www.rki.de/EN/Content/infections/epidemiology/outbreaks/COVID-19/Situationsberichte_Tab.html;jsessionid=3C20A28A08C4D914D28021EC361C7877.internet121 . Accessed Aug 5, 2022.

Auteurs

Anne Berghöfer (A)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. anne.berghoefer@charite.de.

Gabriele Rotter (G)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Joachim Pankert (J)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Katja Icke (K)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Stephanie Roll (S)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Ryan King (R)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Stefan N Willich (SN)

Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH